| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Renal Insufficiency, Chronic | 25 | 2021 | 2654 | 2.70 | Why? |
| Fabry Disease | 7 | 2021 | 106 | 2.40 | Why? |
| Kidney Tubules | 9 | 2018 | 205 | 1.77 | Why? |
| Kidney Diseases | 10 | 2019 | 1434 | 1.54 | Why? |
| Enzyme Replacement Therapy | 5 | 2018 | 65 | 1.40 | Why? |
| alpha-Galactosidase | 5 | 2018 | 32 | 1.29 | Why? |
| Apoptosis | 11 | 2020 | 2335 | 1.21 | Why? |
| Cytokine TWEAK | 5 | 2018 | 16 | 1.21 | Why? |
| Albuminuria | 5 | 2019 | 164 | 1.20 | Why? |
| Diabetic Nephropathies | 5 | 2018 | 315 | 0.97 | Why? |
| Acute Kidney Injury | 10 | 2021 | 5762 | 0.91 | Why? |
| Glomerular Filtration Rate | 9 | 2018 | 1262 | 0.86 | Why? |
| Succinate Dehydrogenase | 1 | 2019 | 16 | 0.81 | Why? |
| Protein-Energy Malnutrition | 1 | 2019 | 37 | 0.77 | Why? |
| Febuxostat | 1 | 2018 | 29 | 0.76 | Why? |
| Ergocalciferols | 2 | 2019 | 51 | 0.74 | Why? |
| Proteomics | 3 | 2019 | 2481 | 0.73 | Why? |
| Toxins, Biological | 2 | 2018 | 40 | 0.72 | Why? |
| Tumor Necrosis Factors | 3 | 2016 | 28 | 0.68 | Why? |
| NF-kappa B p50 Subunit | 1 | 2017 | 64 | 0.67 | Why? |
| Gout | 1 | 2018 | 85 | 0.67 | Why? |
| Uremia | 1 | 2017 | 50 | 0.66 | Why? |
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 3 | 0.66 | Why? |
| Renal Dialysis | 10 | 2021 | 4358 | 0.66 | Why? |
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 30 | 0.65 | Why? |
| Proprotein Convertase 9 | 1 | 2018 | 141 | 0.64 | Why? |
| Nephritis | 2 | 2018 | 39 | 0.60 | Why? |
| Anticholesteremic Agents | 1 | 2018 | 186 | 0.60 | Why? |
| Kidney | 11 | 2020 | 3648 | 0.59 | Why? |
| Reperfusion Injury | 2 | 2017 | 178 | 0.57 | Why? |
| NF-kappa B | 9 | 2019 | 1301 | 0.57 | Why? |
| Kidney Tubules, Proximal | 5 | 2018 | 178 | 0.57 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.57 | Why? |
| Nutrition Assessment | 1 | 2019 | 527 | 0.57 | Why? |
| Lipid Metabolism | 3 | 2018 | 572 | 0.57 | Why? |
| Podocytes | 3 | 2018 | 82 | 0.54 | Why? |
| Glucuronidase | 3 | 2018 | 103 | 0.50 | Why? |
| Carcinoma, Renal Cell | 1 | 2019 | 545 | 0.47 | Why? |
| Kidney Failure, Chronic | 5 | 2021 | 3222 | 0.47 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.46 | Why? |
| Renal Replacement Therapy | 1 | 2021 | 1530 | 0.45 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.45 | Why? |
| Caspase 12 | 1 | 2010 | 7 | 0.44 | Why? |
| Kidney Neoplasms | 1 | 2019 | 832 | 0.42 | Why? |
| Interleukins | 1 | 2016 | 762 | 0.41 | Why? |
| Hyperplasia | 1 | 2009 | 204 | 0.37 | Why? |
| Folic Acid | 5 | 2018 | 172 | 0.37 | Why? |
| Sodium Chloride, Dietary | 2 | 2019 | 62 | 0.36 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 47 | 0.36 | Why? |
| Cardiovascular Diseases | 10 | 2019 | 11497 | 0.36 | Why? |
| Physician's Role | 1 | 2017 | 853 | 0.35 | Why? |
| Inflammation | 10 | 2020 | 13255 | 0.35 | Why? |
| Connective Tissue Growth Factor | 2 | 2018 | 8 | 0.34 | Why? |
| Epithelium | 1 | 2009 | 330 | 0.33 | Why? |
| Mice, Inbred C57BL | 12 | 2020 | 5542 | 0.33 | Why? |
| Phenols | 2 | 2018 | 226 | 0.30 | Why? |
| Receptors, Notch | 2 | 2018 | 59 | 0.30 | Why? |
| Oxidative Stress | 6 | 2021 | 2050 | 0.30 | Why? |
| Animals | 34 | 2020 | 78931 | 0.30 | Why? |
| Molecular Targeted Therapy | 4 | 2018 | 1579 | 0.30 | Why? |
| Transcriptome | 4 | 2020 | 3466 | 0.29 | Why? |
| Macrophages | 3 | 2016 | 2784 | 0.29 | Why? |
| TWEAK Receptor | 2 | 2018 | 46 | 0.29 | Why? |
| Quality of Health Care | 1 | 2017 | 1948 | 0.29 | Why? |
| Benzhydryl Compounds | 2 | 2018 | 240 | 0.28 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 127 | 0.27 | Why? |
| Nephrology | 2 | 2021 | 546 | 0.27 | Why? |
| Mice, Knockout | 8 | 2020 | 1815 | 0.27 | Why? |
| ErbB Receptors | 2 | 2018 | 320 | 0.27 | Why? |
| Analgesics, Non-Narcotic | 1 | 2005 | 164 | 0.26 | Why? |
| Cell Survival | 4 | 2021 | 1581 | 0.26 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.26 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 1510 | 0.25 | Why? |
| Otolaryngology | 1 | 2017 | 1917 | 0.25 | Why? |
| Mice | 17 | 2020 | 21357 | 0.24 | Why? |
| Humans | 84 | 2021 | 930598 | 0.24 | Why? |
| Acetaminophen | 1 | 2005 | 326 | 0.23 | Why? |
| Dyslipidemias | 2 | 2018 | 791 | 0.23 | Why? |
| Sulfones | 2 | 2018 | 66 | 0.22 | Why? |
| Fibrosis | 4 | 2018 | 800 | 0.22 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.22 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2019 | 71 | 0.22 | Why? |
| Nephrectomy | 2 | 2019 | 406 | 0.22 | Why? |
| Hypertension | 5 | 2019 | 8895 | 0.21 | Why? |
| Arginine Vasopressin | 1 | 2019 | 14 | 0.21 | Why? |
| Cells, Cultured | 7 | 2021 | 5835 | 0.21 | Why? |
| Dehydration | 1 | 2019 | 51 | 0.20 | Why? |
| Wasting Syndrome | 1 | 2019 | 42 | 0.20 | Why? |
| Cell Line | 11 | 2018 | 12040 | 0.20 | Why? |
| DNA Modification Methylases | 1 | 2018 | 11 | 0.19 | Why? |
| Aspirin | 2 | 2018 | 1043 | 0.19 | Why? |
| RNA, Small Interfering | 2 | 2017 | 817 | 0.19 | Why? |
| Caseins | 1 | 2018 | 32 | 0.19 | Why? |
| Germ-Line Mutation | 1 | 2019 | 86 | 0.19 | Why? |
| Water-Electrolyte Balance | 1 | 2019 | 136 | 0.19 | Why? |
| Fructose | 1 | 2019 | 52 | 0.19 | Why? |
| Chemokine CCL20 | 1 | 2018 | 47 | 0.19 | Why? |
| Early Diagnosis | 2 | 2018 | 2443 | 0.19 | Why? |
| Carbohydrates | 1 | 2018 | 51 | 0.19 | Why? |
| Accidents | 1 | 2018 | 42 | 0.18 | Why? |
| Immunohistochemistry | 3 | 2019 | 2275 | 0.18 | Why? |
| Intramolecular Oxidoreductases | 1 | 2018 | 38 | 0.18 | Why? |
| Receptors, Cell Surface | 2 | 2020 | 586 | 0.18 | Why? |
| Gene Expression Regulation | 5 | 2018 | 4020 | 0.18 | Why? |
| Antigens, Differentiation, B-Lymphocyte | 1 | 2018 | 54 | 0.18 | Why? |
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 245 | 0.18 | Why? |
| Hematologic Agents | 1 | 2018 | 57 | 0.18 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2018 | 77 | 0.18 | Why? |
| Endothelial Cells | 2 | 2021 | 2048 | 0.18 | Why? |
| Earthquakes | 1 | 2021 | 165 | 0.18 | Why? |
| Histone Deacetylase Inhibitors | 1 | 2018 | 79 | 0.18 | Why? |
| Endothelium, Vascular | 2 | 2021 | 1751 | 0.18 | Why? |
| Polyarteritis Nodosa | 1 | 2017 | 25 | 0.18 | Why? |
| Exome | 1 | 2019 | 207 | 0.18 | Why? |
| Peptides | 3 | 2021 | 2513 | 0.17 | Why? |
| Cytoskeleton | 1 | 2018 | 99 | 0.17 | Why? |
| Endothelin-Converting Enzymes | 1 | 2016 | 1 | 0.17 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.17 | Why? |
| Cytokines | 5 | 2020 | 15010 | 0.17 | Why? |
| Kidney Tubular Necrosis, Acute | 1 | 2017 | 56 | 0.17 | Why? |
| Cytoplasm | 1 | 2019 | 304 | 0.17 | Why? |
| Necrosis | 2 | 2018 | 532 | 0.17 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 334 | 0.17 | Why? |
| Hemodiafiltration | 1 | 2018 | 65 | 0.17 | Why? |
| Epithelial-Mesenchymal Transition | 2 | 2018 | 242 | 0.17 | Why? |
| Lysosomes | 1 | 2021 | 416 | 0.17 | Why? |
| Calcifediol | 1 | 2019 | 191 | 0.17 | Why? |
| Erdheim-Chester Disease | 1 | 2017 | 50 | 0.17 | Why? |
| Liquid Biopsy | 1 | 2017 | 114 | 0.17 | Why? |
| Pentoxifylline | 1 | 2018 | 80 | 0.17 | Why? |
| Lipoxins | 1 | 2017 | 64 | 0.17 | Why? |
| Cyclonic Storms | 1 | 2021 | 236 | 0.17 | Why? |
| Angiotensins | 1 | 2018 | 259 | 0.17 | Why? |
| Endothelin-1 | 1 | 2016 | 69 | 0.16 | Why? |
| Sodium-Glucose Transporter 2 | 1 | 2017 | 111 | 0.16 | Why? |
| Anemia, Hemolytic | 1 | 2018 | 70 | 0.16 | Why? |
| Hemorrhage | 3 | 2018 | 3013 | 0.16 | Why? |
| Parathyroid Hormone | 1 | 2017 | 98 | 0.16 | Why? |
| Disease Progression | 8 | 2018 | 13580 | 0.16 | Why? |
| Thiazoles | 2 | 2018 | 496 | 0.16 | Why? |
| Hydrogen Sulfide | 1 | 2017 | 86 | 0.16 | Why? |
| Polymers | 2 | 2018 | 507 | 0.16 | Why? |
| Support Vector Machine | 1 | 2018 | 330 | 0.16 | Why? |
| Energy Metabolism | 2 | 2017 | 451 | 0.16 | Why? |
| Albumins | 1 | 2018 | 324 | 0.16 | Why? |
| NADH, NADPH Oxidoreductases | 1 | 2015 | 2 | 0.15 | Why? |
| Histones | 1 | 2018 | 371 | 0.15 | Why? |
| Disease Models, Animal | 8 | 2019 | 10998 | 0.15 | Why? |
| Uric Acid | 1 | 2018 | 285 | 0.15 | Why? |
| Histocompatibility Antigens Class II | 1 | 2018 | 383 | 0.15 | Why? |
| Body Composition | 1 | 2019 | 414 | 0.15 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.14 | Why? |
| Rhabdomyolysis | 1 | 2019 | 287 | 0.14 | Why? |
| Breast | 1 | 2017 | 290 | 0.14 | Why? |
| Calcinosis | 1 | 2017 | 240 | 0.14 | Why? |
| Interleukin-1 | 1 | 2018 | 438 | 0.14 | Why? |
| Muscle, Smooth, Vascular | 1 | 2015 | 86 | 0.14 | Why? |
| Aorta | 1 | 2017 | 355 | 0.14 | Why? |
| Myositis | 1 | 2017 | 185 | 0.14 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.14 | Why? |
| Global Burden of Disease | 1 | 2018 | 531 | 0.14 | Why? |
| Expert Testimony | 1 | 2018 | 658 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2016 | 581 | 0.13 | Why? |
| Cholesterol, LDL | 1 | 2018 | 499 | 0.13 | Why? |
| Galectin 3 | 1 | 2014 | 76 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.13 | Why? |
| Signal Transduction | 5 | 2018 | 7207 | 0.13 | Why? |
| Male | 35 | 2021 | 367725 | 0.13 | Why? |
| Myocytes, Smooth Muscle | 1 | 2015 | 127 | 0.13 | Why? |
| Chemokine CXCL16 | 1 | 2012 | 7 | 0.13 | Why? |
| Curcumin | 1 | 2019 | 396 | 0.13 | Why? |
| Risk Factors | 10 | 2019 | 71621 | 0.13 | Why? |
| Receptors, Scavenger | 1 | 2012 | 24 | 0.13 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.13 | Why? |
| Plaque, Atherosclerotic | 1 | 2018 | 423 | 0.13 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.13 | Why? |
| Chemokines, CXC | 1 | 2012 | 68 | 0.12 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.12 | Why? |
| Vascular Calcification | 1 | 2017 | 396 | 0.12 | Why? |
| Environmental Pollutants | 1 | 2017 | 320 | 0.12 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.12 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.12 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.12 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.12 | Why? |
| Calcium | 1 | 2017 | 708 | 0.12 | Why? |
| Muscle, Skeletal | 1 | 2019 | 915 | 0.12 | Why? |
| Female | 30 | 2021 | 380317 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.11 | Why? |
| Aged | 21 | 2021 | 215776 | 0.11 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.11 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Cell Death | 2 | 2017 | 536 | 0.11 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.11 | Why? |
| Carotid Artery Diseases | 1 | 2014 | 251 | 0.11 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.11 | Why? |
| Transcription Factor CHOP | 1 | 2010 | 29 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.10 | Why? |
| Metformin | 1 | 2017 | 640 | 0.10 | Why? |
| Reactive Oxygen Species | 2 | 2021 | 1136 | 0.10 | Why? |
| Cyclin D1 | 1 | 2009 | 22 | 0.10 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.10 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 40 | 0.10 | Why? |
| Ischemia | 1 | 2017 | 901 | 0.10 | Why? |
| Follow-Up Studies | 5 | 2019 | 17020 | 0.10 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.10 | Why? |
| Transcription, Genetic | 2 | 2016 | 1326 | 0.09 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.09 | Why? |
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 40 | 0.09 | Why? |
| Noncommunicable Diseases | 1 | 2018 | 934 | 0.09 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.09 | Why? |
| Osteoprotegerin | 1 | 2008 | 32 | 0.09 | Why? |
| Nutritional Status | 1 | 2019 | 1403 | 0.09 | Why? |
| Diet | 2 | 2018 | 2052 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Apolipoproteins E | 1 | 2009 | 170 | 0.09 | Why? |
| Peripheral Arterial Disease | 1 | 2014 | 471 | 0.09 | Why? |
| Fibroblast Growth Factors | 2 | 2019 | 119 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.09 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.09 | Why? |
| Heme Oxygenase-1 | 2 | 2019 | 90 | 0.09 | Why? |
| Blood Vessels | 1 | 2009 | 228 | 0.09 | Why? |
| Hypoglycemic Agents | 2 | 2017 | 2165 | 0.08 | Why? |
| Spain | 4 | 2020 | 15545 | 0.08 | Why? |
| Heat-Shock Proteins | 1 | 2010 | 226 | 0.08 | Why? |
| Endoplasmic Reticulum | 1 | 2010 | 430 | 0.08 | Why? |
| Hyperlipidemias | 1 | 2009 | 290 | 0.08 | Why? |
| MAP Kinase Signaling System | 2 | 2020 | 360 | 0.08 | Why? |
| Jagged-1 Protein | 2 | 2018 | 3 | 0.08 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.08 | Why? |
| Membranes, Artificial | 2 | 2018 | 175 | 0.08 | Why? |
| Epithelial Cells | 3 | 2012 | 3508 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.08 | Why? |
| Angiotensin II | 1 | 2012 | 601 | 0.08 | Why? |
| Recombinant Proteins | 4 | 2018 | 3786 | 0.08 | Why? |
| Fibrinolytic Agents | 1 | 2017 | 1702 | 0.08 | Why? |
| Turkey | 1 | 2016 | 3937 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.07 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.07 | Why? |
| bcl-2-Associated X Protein | 1 | 2005 | 45 | 0.07 | Why? |
| bcl-X Protein | 1 | 2005 | 19 | 0.07 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.07 | Why? |
| Life Style | 1 | 2018 | 2708 | 0.07 | Why? |
| Carotid Intima-Media Thickness | 2 | 2018 | 179 | 0.07 | Why? |
| Adult | 11 | 2019 | 244371 | 0.07 | Why? |
| Caspases | 1 | 2005 | 156 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Biopsy | 2 | 2017 | 2811 | 0.07 | Why? |
| Rats | 3 | 2018 | 2764 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| NF-E2-Related Factor 2 | 2 | 2018 | 373 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2017 | 2107 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.07 | Why? |
| Glucose | 1 | 2008 | 573 | 0.06 | Why? |
| Antibodies, Monoclonal | 3 | 2018 | 8041 | 0.06 | Why? |
| RNA, Messenger | 3 | 2018 | 5131 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Down-Regulation | 2 | 2020 | 1416 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Renin-Angiotensin System | 1 | 2018 | 3661 | 0.06 | Why? |
| Ligands | 1 | 2008 | 1300 | 0.06 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.06 | Why? |
| Prognosis | 4 | 2018 | 32490 | 0.06 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| In Vitro Techniques | 2 | 2016 | 1027 | 0.06 | Why? |
| Membrane Proteins | 3 | 2019 | 1733 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.06 | Why? |
| CD40 Ligand | 1 | 2021 | 121 | 0.06 | Why? |
| Chronic Disease | 1 | 2016 | 5139 | 0.05 | Why? |
| Fibroblasts | 2 | 2018 | 839 | 0.05 | Why? |
| Linear Models | 2 | 2017 | 1914 | 0.05 | Why? |
| Osmolar Concentration | 1 | 2019 | 86 | 0.05 | Why? |
| Amino Acid Transport Systems | 1 | 2019 | 7 | 0.05 | Why? |
| Trihexosylceramides | 1 | 2018 | 2 | 0.05 | Why? |
| Cholesterol Ester Transfer Proteins | 1 | 2018 | 8 | 0.05 | Why? |
| Interleukin-2 | 1 | 2021 | 443 | 0.05 | Why? |
| Fibric Acids | 1 | 2018 | 15 | 0.05 | Why? |
| Up-Regulation | 2 | 2018 | 2249 | 0.05 | Why? |
| Nephrologists | 1 | 2020 | 117 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 9335 | 0.05 | Why? |
| Intestinal Absorption | 1 | 2019 | 64 | 0.05 | Why? |
| Cryopyrin-Associated Periodic Syndromes | 1 | 2018 | 20 | 0.05 | Why? |
| Receptors, CCR6 | 1 | 2018 | 45 | 0.05 | Why? |
| Acrylic Resins | 1 | 2018 | 48 | 0.05 | Why? |
| Acetylation | 1 | 2018 | 124 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Chemotaxis, Leukocyte | 1 | 2018 | 82 | 0.05 | Why? |
| NF-E2-Related Factor 1 | 1 | 2018 | 3 | 0.05 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2018 | 6 | 0.05 | Why? |
| Isoenzymes | 1 | 2018 | 127 | 0.05 | Why? |
| G2 Phase Cell Cycle Checkpoints | 1 | 2018 | 25 | 0.05 | Why? |
| Receptor, trkA | 1 | 2018 | 10 | 0.05 | Why? |
| Interleukin-1alpha | 1 | 2018 | 42 | 0.05 | Why? |
| Nutrition Disorders | 1 | 2018 | 37 | 0.05 | Why? |
| Amyloid Precursor Protein Secretases | 1 | 2018 | 38 | 0.05 | Why? |
| Symporters | 1 | 2019 | 80 | 0.05 | Why? |
| Diamines | 1 | 2018 | 83 | 0.05 | Why? |
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 39 | 0.05 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.05 | Why? |
| Antioxidants | 2 | 2019 | 1593 | 0.05 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 66 | 0.05 | Why? |
| Mice, Inbred BALB C | 1 | 2009 | 5814 | 0.04 | Why? |
| Electrophoresis, Capillary | 1 | 2017 | 39 | 0.04 | Why? |
| Calcium Oxalate | 1 | 2017 | 14 | 0.04 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.04 | Why? |
| NIH 3T3 Cells | 1 | 2018 | 147 | 0.04 | Why? |
| Cellulose | 1 | 2018 | 106 | 0.04 | Why? |
| Myoglobin | 1 | 2019 | 143 | 0.04 | Why? |
| Oxalates | 1 | 2017 | 12 | 0.04 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.04 | Why? |
| Methylamines | 1 | 2017 | 23 | 0.04 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.04 | Why? |
| Permeability | 1 | 2018 | 238 | 0.04 | Why? |
| Phosphatidylcholines | 1 | 2017 | 68 | 0.04 | Why? |
| Back Pain | 1 | 2018 | 115 | 0.04 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.04 | Why? |
| Tyrosine | 1 | 2017 | 66 | 0.04 | Why? |
| Carnitine | 1 | 2017 | 47 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| Histiocytes | 1 | 2017 | 97 | 0.04 | Why? |
| Transcription Factor AP-1 | 1 | 2016 | 75 | 0.04 | Why? |
| Neck Pain | 1 | 2018 | 126 | 0.04 | Why? |
| Choline | 1 | 2017 | 77 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2019 | 437 | 0.04 | Why? |
| Phosphates | 1 | 2017 | 135 | 0.04 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2010 | 3607 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.04 | Why? |
| Mass Screening | 1 | 2016 | 8005 | 0.04 | Why? |
| Granuloma | 1 | 2017 | 88 | 0.04 | Why? |
| Leg | 1 | 2017 | 142 | 0.04 | Why? |
| Atherosclerosis | 2 | 2018 | 768 | 0.04 | Why? |
| Nervous System | 1 | 2018 | 303 | 0.04 | Why? |
| Collagen | 1 | 2017 | 222 | 0.04 | Why? |
| Bone Diseases | 1 | 2017 | 101 | 0.04 | Why? |
| Aging | 1 | 2012 | 3581 | 0.04 | Why? |
| Cisplatin | 1 | 2017 | 209 | 0.04 | Why? |
| STAT3 Transcription Factor | 1 | 2018 | 268 | 0.04 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.04 | Why? |
| NADPH Oxidase 1 | 1 | 2015 | 2 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.04 | Why? |
| Systems Biology | 1 | 2018 | 320 | 0.04 | Why? |
| Tryptophan | 1 | 2017 | 218 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2017 | 387 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.04 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2014 | 23 | 0.04 | Why? |
| Protein Processing, Post-Translational | 1 | 2018 | 634 | 0.04 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.04 | Why? |
| Fatty Acids, Omega-3 | 1 | 2018 | 306 | 0.04 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2017 | 239 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.04 | Why? |
| Proteinuria | 1 | 2018 | 474 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.03 | Why? |
| Endocytosis | 1 | 2018 | 451 | 0.03 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.03 | Why? |
| NADPH Oxidases | 1 | 2014 | 80 | 0.03 | Why? |
| Disease Susceptibility | 1 | 2008 | 4002 | 0.03 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.03 | Why? |
| Infant, Newborn, Diseases | 1 | 2018 | 394 | 0.03 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.03 | Why? |
| Transfection | 1 | 2016 | 864 | 0.03 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.03 | Why? |
| Serrate-Jagged Proteins | 1 | 2012 | 1 | 0.03 | Why? |
| Accidents, Traffic | 1 | 2018 | 464 | 0.03 | Why? |
| Microscopy, Confocal | 1 | 2015 | 343 | 0.03 | Why? |
| Insulin Resistance | 1 | 2019 | 669 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2018 | 919 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| Cell Membrane | 1 | 2018 | 743 | 0.03 | Why? |
| Pharmaceutical Preparations | 1 | 2008 | 1897 | 0.03 | Why? |
| Inflammation Mediators | 2 | 2018 | 2654 | 0.03 | Why? |
| Prednisone | 1 | 2017 | 652 | 0.03 | Why? |
| Hydronephrosis | 1 | 2012 | 28 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2016 | 823 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Tertiary Healthcare | 1 | 2017 | 616 | 0.03 | Why? |
| Imidazoles | 1 | 2018 | 631 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Calcium-Binding Proteins | 1 | 2012 | 121 | 0.03 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.03 | Why? |
| Nitric Oxide | 1 | 2019 | 769 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.03 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2012 | 160 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.03 | Why? |
| Age Factors | 1 | 2012 | 21039 | 0.03 | Why? |
| Transforming Growth Factor beta1 | 1 | 2012 | 204 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Diet, Atherogenic | 1 | 2009 | 1 | 0.03 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Pain | 1 | 2018 | 1084 | 0.03 | Why? |
| Intestinal Mucosa | 1 | 2018 | 1046 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.03 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.03 | Why? |
| Vitamins | 1 | 2019 | 1208 | 0.02 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2018 | 1165 | 0.02 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.02 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.02 | Why? |
| Lipoproteins, LDL | 1 | 2009 | 115 | 0.02 | Why? |
| Ferritins | 1 | 2018 | 2055 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Disaster Planning | 1 | 2021 | 1680 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2018 | 1585 | 0.02 | Why? |
| Disabled Persons | 1 | 2018 | 1152 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Methylprednisolone | 1 | 2017 | 2107 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Patient Care Management | 1 | 2017 | 1514 | 0.02 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2019 | 1782 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2017 | 3347 | 0.02 | Why? |
| Blood Pressure | 1 | 2016 | 2198 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.02 | Why? |
| Vitamin D | 1 | 2019 | 2904 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.02 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Monocytes | 1 | 2014 | 2978 | 0.01 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Gene Expression | 1 | 2009 | 3332 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.00 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |